The Impact of β2-Microglobulin Clearance on the Risk Factors of Cardiovascular Disease in Hemodialysis Patients
- 1 July 2010
- journal article
- research article
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 56 (4) , 326-332
Abstract
β2-Microglobulin (β2M) is an independent predictor of outcome for hemodialysis (HD) patients and a representative substance of middle molecules. We tested the relationship among serum β2M levels and cardiovascular disease (CVD) risk factors in HD patients. A total of 132 HD patients were divided according to the dialysis membrane used [property; cellulose and synthetic or β2M clearance; low filtration (LF), middle filtration (MF), and high filtration (HF)]. There was no significant difference in CVD risk factors between cellulose and synthetic groups. On the other hand, serum β2M, highly-sensitive C-reactive protein (hCRP), troponin-T (TnT), and myeloperoxidase (MPO) levels of LF were significantly higher and those of prealbumin (PA) were lower than the MF and HF. Serum β2M level was positively correlated with hCRP, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), MPO, TnT, N-terminal pro-B-type natriuretic peptide (NT-proBNP) and inversely correlated with PA and ankle-brachial index (ABI). There was a significant correlation between serum β2M levels and various CVD risk factors in HD. Cardiovascular disease risk factors in HD patients were dependent on the β2M clearance but not membrane property.Keywords
This publication has 24 references indexed in Scilit:
- Cardiac biomarkers are influenced by dialysis characteristicsClinical Nephrology, 2007
- Relationships of N-Terminal Pro–B-Natriuretic Peptide and Cardiac Troponin T to Left Ventricular Mass and Function and Mortality in Asymptomatic Hemodialysis PatientsAmerican Journal of Kidney Diseases, 2007
- Measuring risk in end-stage renal disease: Is N-terminal pro brain natriuretic peptide a useful marker?Kidney International, 2007
- β2-microglobulin, a uremic toxin with a double meaningKidney International, 2006
- Serum β-2 Microglobulin Levels Predict Mortality in Dialysis PatientsJournal of the American Society of Nephrology, 2006
- Serum Albumin, C-Reactive Protein, Interleukin 6, and Fetuin A as Predictors of Malnutrition, Cardiovascular Disease, and Mortality in Patients With ESRDAmerican Journal of Kidney Diseases, 2006
- Dialyzer membrane permeability and survival in hemodialysis patientsAmerican Journal of Kidney Diseases, 2005
- β2-microglobulin as a potential initiator of inflammatory responsesTrends in Immunology, 2003
- β2-microglobulin as a negative growth regulator of myeloma cellsBritish Journal of Haematology, 2002
- Inflammation enhances cardiovascular risk and mortality in hemodialysis patientsKidney International, 1999